artificial intelligence
| 4 min read
Novel Alzheimer’s screening tests, promising weight loss drug data, an AI model linking sleep to disease risk, and more led the news this week.
| 4 min read
By reengineering small-molecule chemistry for automation, Excelsior aims to remove a long-standing barrier to AI-driven drug discovery.
| 4 min read
Investments in solid tumor targets and autoimmune disease, success for a peanut allergy patch, a promising CAR T cell therapy for stiff person syndrome, and more led the news this week.
| 9 min read
Rather than replacing radiologists, AI is working alongside them to catch cancers earlier and improve screening efficiency.
| 4 min read
Billion-dollar partnerships, Phase 1 wins, AI regulatory tools, and more led the news this week.
| 3 min read
The partnership leverages real-world patient data and advanced analytics to support faster, more patient-centered drug discovery.
| 4 min read
A new deep learning model combines dermoscopic images with patient data to improve accuracy and reduce false positives.
| 6 min read
New AI tools promise to speed up and simplify CRISPR experiments, but their real-world impact is still being tested.
| 5 min read
Quantum-informed AI could open up unexplored chemical space, speeding the design of safer, more effective drugs.
| 6 min read
Harnessing human-first models to accelerate drug discovery, improve safety, and capture the diversity of human biology.
